Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1209 (LINC01209)

Target
LINC01209
Molecular classification
Other (Long intergenic non-coding RNA; lincRNA; long non-coding RNA)
01

Overview

Long intergenic non-protein coding RNA 1209 (LINC01209) is a long intergenic non-coding RNA (lincRNA), which refers to an autonomously transcribed RNA longer than 200 nucleotides that does not overlap with annotated protein-coding genes[1][3][7][9]. LincRNAs, including LINC01209, are members of the broader long non-coding RNA (lncRNA) family. They have been shown to participate in diverse regulatory functions such as modification of chromatin structure, stabilization of RNA, transcriptional regulation, and possibly enhancer function, often with remarkable tissue specificity[3][5][9]. LincRNAs generally act to fine-tune the expression of neighboring or distant genes, but for most individual lincRNAs, including LINC01209, their precise biological roles and disease associations remain poorly characterized and under active investigation[3][9]. There is currently no evidence that LINC01209 is a recognized therapeutic target, nor are there approved drugs or established biomarker uses for this RNA.

Other names
LINC01209
02

Biological functions

Gene expression regulationChromatin remodelingRNA stabilizationTranscriptional regulationPotential enhancer-associated activity
03

Disease associations

Other (Potential association with disease is possible, but no clear, specific disease role has been established for LINC01209 itself)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1209 (LINC01209).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1209 (LINC01209).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call